<?xml version="1.0" encoding="UTF-8"?>
<p>Bevacizumab has been reported by the American Heart Association to be an agent that may either cause reversible direct myocardial toxicity or exacerbate underlying myocardial dysfunction Moreover, bevacizumab has been reported to cause and/or worsen hypertension [
 <xref rid="B98-pharmaceuticals-13-00096" ref-type="bibr">98</xref>]. Thus, blood pressure monitoring during bevacizumab treatment and regularly after discontinuation is recommended.
</p>
